Trial NCT04596033

View at ClinicalTrials.gov 
Org. Study IDs: GEN-011-101

Last trial update was posted on 2022-07-15

MeSH Interventions

Cyclophosphamide Fludarabine Interleukin-2

MeSH Conditions

Carcinoma Carcinoma, Merkel Cell Carcinoma, Squamous Cell Lung Neoplasms Melanoma Small Cell Lung Carcinoma Squamous Cell Carcinoma of Head and Neck

Other Conditions

Anal Squamous Cell Carcinoma Cutaneous Squamous Cell Carcinoma Merkel Cell Carcinoma Non-small Cell Lung Cancer Renal Cell Carcinoma Small-cell Lung Cancer Urothelial Carcinoma

Stopping Reasons

Business reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID